Skip to main content
. 2021 Oct 11;269(5):2513–2526. doi: 10.1007/s00415-021-10820-2

Table 4.

Change in EDSS for all patients with RRMS segregated by pre-HSCT EDSS and for SPMS segregated by MRI enhancement within the prior year

Patients EDSS: pre-HSCT baseline EDSS: 6 months EDSS: 1 year EDSS: 2 years EDSS: 3 years EDSS: 4 years EDSS: 5 years
RRMS

RRMS ALL@

Mean, median,

(range),

STD, 1st Q, 3rd Q

(number)

Δ EDSS P value

3.87, 3.5

(1–8) @

1.43, 3, 4

(n = 414)

2.70, 2.5

(0–7)

1.48, 2, 3.25

(n = 259)

P < 0.001

2.51, 2

(0–7)

1.48, 1.5, 3

(n = 299)

P < 0.001

2.50, 2

(0–7.5)

1.60, 1.5, 3

(n = 224)

P < 0.001

2.41, 2

(0–7.5)

1.61, 1.5, 3

(n = 158)

P < 0.001

2.33, 2

(0–7.5)

1.75, 1, 3

(n = 96)

P < 0.001

2.19, 2

(0–6.5)

1.70, 1, 3

(n = 80)

P < 0.001

RRMS Pre-HSCT EDSS 2–4 @

Mean, median,

(range),

STD, 1st Q, 3rd Q

(number)

Δ EDSS P value

3.14, 3

(1–4) @

0.66, 2.5, 3.5

(n = 302)

2.17, 2

(0–4)

0.99, 2.5, 3.5

(n = 179)

P < 0.001

2.03, 2

(0–6)

1.06, 1.5–2.5

(n = 14)

P < 0.001

1.99, 2

(0–5.5)

1.15, 1.37, 2.5

(n = 160)

P < 0.001

1.94, 2

(0–6)

1.15, 1, 2.5

(n = 114)

P < 0.001

1.78, 1.5

(0–6.5)

1.18, 1, 2

(n = 63)

P < 0.001

1.95, 1,5

(0–6.5)

1.65, 1, 2.5

(n = 58)

P < 0.001

RRMS Pre-HSCT EDSS 4.5–6

Mean, median,

(range),

STD, 1st Q, 3rd Q

(number)

Δ EDSS P value

5.5, 5.75

(4.5–6)

0.58, 5, 6

(n = 74)

3.38, 3

(0–6.5)

1.52, 2.4, 4.5

(n = 56)

P < 0.001

3,21, 3

(0–6.5)

1.54, 2.5, 4

(n = 57)

P < 0.001

2.81, 2.5

(0–6.5)

1.34, 2, 3,4

(n = 38)

P < 0.001

2.85, 2.5

(0–6.5)

1.59, 1.5, 3.75

(n = 27)

P < 0.001

2.5, 2.25

(0–6)

1.84, 1.37, 4

(n = 20)

P < 0.001

2.38, 2

(0–6)

1.73, 1, 3

(n = 13)

P < 0.001

RRMS Pre-HSCT EDSS 6.5

Mean, median,

(range),

STD, 1st Q, 3rd Q

(number)

Δ EDSS P value

6.5, 6.5

6.5

0, 6.5, 6.5

(n = 30)

5.13, 6

(2.5–7)

1.43, 4, 6,5

(n = 19)

P < 0.001

4.88, 5

(2.5–7)

1,41, 3.5, 6

(n = 22)

P < 0.001

5.21, 6

(2.5–7.5)

1.54, 4, 6.5

(n = 21)

P = 0.001

5.1, 6

(1–7.5)

1.91, 4.1, 6.3

(n-14)

P = 0.02

4.88, 5.5

(0–5.5)

2.02, 4, 6

(n = 12)

P = 0.01

3.37, 3.75

(0–6)

1.7, 2.8, 4

(n = 8)

P < 0.001

RRMS Pre-HSCT EDSS 7–8

Mean, median,

(range),

STD, 1st Q, 3rd Q

(number)

Δ EDSS P value

7.13, 7

(7–8)

0.45, 7, 7.6

(n = 8)

5.5, 6

(4–6)

1.0, 5.5, 6

(n = 4)

P = 0.05

4.6, 5

(3–6)

1.51, 3, 6

(n = 4)

P = 0.05

SPMS
All SPMS

Mean, median,

(range),

STD, 1st Q, 3rd Q

(number)

Δ EDSS P value

5.09, 5.5

(3–8)

1.32, 3, 6

n = 93

4.71, 4.25

(1–8)

1.56, 3.5, 6

n = 54

P < 0.001

4.85, 5.25

(2–6.5)

1.39, 3.5, 6

n = 64

P = 0.04

4.88, 5.5

(1.5–7)

1.54, 3.5, 6.5

n = 45

P = 0.20

4.92, 6

(0–7)

1.77, 3, 6.5

n = 33

p = 0.27

4.72, 6

(1.5–7.5) 1.95, 3, 6.4

n = 22

p = 0.07

4.21, 4

(1.5–6.5)

1.95, 2.5, 6

N = 16

P = 0.21

naSPMS MRI gadolinium negative in prior year

Mean, median,

(range),

STD, 1st Q, 3rd Q

(number)

Δ EDSS P value

4.92, 5

(3–7)

1.26, 3.6, 6

n = 58

4.56, 4

(1–8),

1.57, 3.5, 6

n = 33

p = 0.04

4.88, 5.25

(2–6.5) 1.37, 3.5, 6

n = 38

p = 0.54

5.13, 5.5

(3–7)

1.34, 4, 6.4

n = 26

p = 1.0

4.89, 6

(0–6.5)

1.79, 3.5, 6.26

n = 19

p = 0.74

4.54, 5

(1.5–7.5) 2.15, 2.5, 6

n = 11

p = 0.27

4.71, 6

(1.5–6.5)

2.13, 3.25, 6.25

n = 7

p = 0.75

aSPMS, MRI gadolinium positive in prior year

Mean, median,

(range),

STD, 1st Q, 3rd Q

(number)

Δ EDSS P value

5.37, 6

(3–8)

1.40, 4, 6.5

n = 35

4.95, 5.5

(2–7.5) 1.56. 3.5, 6.5

n = 21

P = 0.002

4.82, 5

(2–6.5)

1.44, 3.5, 6

n = 26

P = 0.001

4.55, 4

(1.5–6.5) 1.76, 3, 6.5

n = 19

P = 0.003

4.93, 6

(2.5–7)

1.8, 3.1, 6.5

n = 14

P = 0.02

4.9, 5.5

(2.5–7) 1.81, 3, 6.5

n = 14

p = 0.1

3.88, 3

(2.5–6.5)

1.83, 2.5, 6

n = 9

p = 0.03

@ while awaiting HSCT a single patient improved to EDSS 1.0. Δ  Change in mean EDSS from mean at baseline, 1st aSPMS  active secondary progressive multiple sclerosis, Q  first quartile, 3rd Q third quartile EDSS = expanded disability status scale, HSCT hematopoietic stem cell transplantation, naSPMS  non-active secondary progressive multiple sclerosis, RRMS relapsing remitting multiple sclerosis, SPMS secondary progressive multiple sclerosis, STD standard deviation